Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study

BACKGROUND: Renal anemia is a common complication in patients with end-stage renal disease (ESRD). Both roxadustat and recombinant human erythropoietin (rhEPO) are alternative option for patients with renal anemia. However, the adverse events of rhEPO limited the wide use of it and the concrete diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Chen, Zhang, Yue, Luo, Chuxuan, Ren, Yan, Ye, Binxian, Hu, Xiao, Li, Yiwen, Zhu, Bin, He, Qiang, Shao, Lina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732703/
https://www.ncbi.nlm.nih.gov/pubmed/36507485
http://dx.doi.org/10.21037/tau-22-709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732703/
https://www.ncbi.nlm.nih.gov/pubmed/36507485
http://dx.doi.org/10.21037/tau-22-709

Ejemplares similares